1. Conventional type I dendritic cells maintain a reservoir of proliferative tumor-antigen specific TCF-1+ CD8+ T cells in tumor-draining lymph nodes
- Author
-
Massachusetts Institute of Technology. Department of Biology, Schenkel, Jason M, Herbst, Rebecca H, Canner, David, Li, Amy, Hillman, Michelle, Shanahan, Sean-Luc, Gibbons, Grace, Smith, Olivia C, Kim, Jonathan Y, Westcott, Peter, Hwang, William L, Freed-Pastor, William A, Eng, George, Cuoco, Michael S, Rogers, Patricia, Park, Jin K, Burger, Megan L, Rozenblatt-Rosen, Orit, Cong, Le, Pauken, Kristen E, Regev, Aviv, Jacks, Tyler, Massachusetts Institute of Technology. Department of Biology, Schenkel, Jason M, Herbst, Rebecca H, Canner, David, Li, Amy, Hillman, Michelle, Shanahan, Sean-Luc, Gibbons, Grace, Smith, Olivia C, Kim, Jonathan Y, Westcott, Peter, Hwang, William L, Freed-Pastor, William A, Eng, George, Cuoco, Michael S, Rogers, Patricia, Park, Jin K, Burger, Megan L, Rozenblatt-Rosen, Orit, Cong, Le, Pauken, Kristen E, Regev, Aviv, and Jacks, Tyler
- Abstract
In tumors, a subset of CD8+ T cells expressing the transcription factor TCF-1 drives the response to immune checkpoint blockade. We examined the mechanisms that maintain these cells in an autochthonous model of lung adenocarcinoma. Longitudinal sampling and single-cell sequencing of tumor-antigen specific TCF-1+ CD8+ T cells revealed that while intratumoral TCF-1+ CD8+ T cells acquired dysfunctional features and decreased in number as tumors progressed, TCF-1+ CD8+ T cell frequency in the tumor draining LN (dLN) remained stable. Two discrete intratumoral TCF-1+ CD8+ T cell subsets developed over time-a proliferative SlamF6+ subset and a non-cycling SlamF6- subset. Blocking dLN egress decreased the frequency of intratumoral SlamF6+ TCF-1+ CD8+ T cells. Conventional type I dendritic cell (cDC1) in dLN decreased in number with tumor progression, and Flt3L+anti-CD40 treatment recovered SlamF6+ T cell frequencies and decreased tumor burden. Thus, cDC1s in tumor dLN maintain a reservoir of TCF-1+ CD8+ T cells and their decrease contributes to failed anti-tumor immunity.
- Published
- 2022